The Cerebellum

, Volume 16, Issue 5–6, pp 938–944 | Cite as

Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10

  • Adriana MoroEmail author
  • Renato P. Munhoz
  • Mariana Moscovich
  • Walter O. Arruda
  • Salmo Raskin
  • Laura Silveira-Moriyama
  • Tetsuo Ashizawa
  • Hélio A. G. Teive
Original Paper


Nonmotor symptoms (NMS) have been described in several neurodegenerative diseases but have not been systematically evaluated in spinocerebellar ataxia type 10 (SCA10). The objective of the study is to compare the frequency of NMS in patients with SCA10, Machado-Joseph disease (MJD), and healthy controls. Twenty-eight SCA10, 28 MJD, and 28 healthy subjects were prospectively assessed using validated screening tools for chronic pain, autonomic symptoms, fatigue, sleep disturbances, psychiatric disorders, and cognitive function. Chronic pain was present with similar prevalence among SCA10 patients and healthy controls but was more frequent in MJD. Similarly, autonomic symptoms were found in SCA10 in the same proportion of healthy individuals, while the MJD group had higher frequencies. Restless legs syndrome and REM sleep behavior disorder were uncommon in SCA10. The mean scores of excessive daytime sleepiness were worse in the SCA10 group. Scores of fatigue were higher in the SCA10 sample compared to healthy individuals, but better than in the MJD. Psychiatric disorders were generally more prevalent in both spinocerebellar ataxias than among healthy controls. The cognitive performance of healthy controls was better compared with SCA10 patients and MJD, which showed the worst scores. Although NMS were present among SCA10 patients in a higher proportion compared to healthy controls, they were more frequent and severe in MJD. In spite of these comparisons, we were able to identify NMS with significant functional impact in patients with SCA10, indicating the need for their systematic screening aiming at optimal treatment and improvement in quality of life.


Spinocerebellar ataxia type 10 Machado-Joseph disease Nonmotor symptoms Spinocerebellar ataxia type 3 


Compliance with Ethical Standards

This study was approved by the institutional ethics committee of the Federal University of Paraná and all patients and healthy controls signed an informed consent.

Conflict of Interest

TA was supported by NIH grant NS083564.


  1. 1.
    Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2008;26:191–4.CrossRefGoogle Scholar
  2. 2.
    Grewal RP, Tayag E, Figueroa KP, Zu L, Durazo A, Nunez C, et al. Clinical and genetic analysis of a distinct autosomal dominant spinocerebellar ataxia. Neurology. 1998;51:1423–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Rasmunssen A, Matsuura T, Ruano L, Yescas P, Ochoa A, Ashizawa T, et al. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol. 2001;50:234–9.CrossRefGoogle Scholar
  4. 4.
    Teive HAG, Munhoz RP, Raskin S, Arruda WO, de Paola L, Werneck LC, et al. Spinocerebellar ataxia type 10: frequency of epilepsy in a large sample of Brazilian patients. Mov Disord. 2010;25:2875–8.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    de Castilhos RM, Furtado GV, Gheno TC, Schaeffer P, Russo A, Barsottini O, et al. Spinocerebellar ataxias in Brazil—frequencies and modulating effects of related genes. Cerebellum. 2014;13:17–28.CrossRefPubMedGoogle Scholar
  6. 6.
    D’Abreu A, Franca MC Jr, Paulson HL, Lopes-Cendes I. Caring for Machado-Joseph disease: current understanding and how to help patients. Parkinsonism Relat Disord. 2010;16:2–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arq Neuropsiquiatr. 2010;68:228–30.CrossRefPubMedGoogle Scholar
  8. 8.
    Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson’s disease. Mov Disord. 1986;1:45–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Low PA. Clinical autonomic disorders: evaluation and management. Little, Brown & Co: Boston, Mass; 1993.Google Scholar
  10. 10.
    Pavan K, Schmidt K, Marangoni B, Mendes MF, Tilbery CP, Lianza S. Multiple sclerosis: cross-cultural adaption and validation of the modified fatigue impact scale. Arq Neuropsiquiatr. 2007;65:669–73.CrossRefPubMedGoogle Scholar
  11. 11.
    Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord. 2007;22:2386–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Masuko AH, Carvalho LB, Machado MA, Morais JF, Prado LB, Prado GF. Translation and validation into the Brazilian Portuguese of the restless legs syndrome rating scale of the International Restless Legs Syndrome Study Group. Arq Neuropsiquiar. 2008;66:832–6.CrossRefGoogle Scholar
  14. 14.
    Gorenstein C, Andrade L, Vieira Filho AH, Tung TC, Artes R. Psychometric properties of the Portuguese version of the Beck Depression Inventory on Brazilian college students. J Clin Psychol. 1999;55:553–62.CrossRefPubMedGoogle Scholar
  15. 15.
    Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1953;32:50–5.CrossRefGoogle Scholar
  16. 16.
    Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr. 2003;61:777–81.CrossRefPubMedGoogle Scholar
  17. 17.
    Dubois B, Slachevsky A, Litvan I, Pillon B, The FAB. A frontal assessment battery at bedside. Neurology. 2000;55:1621–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Freedman M, Kaplan E, Delis D, Morris R. Clock drawing: a neuropsychological analysis. New York: Oxford University Press; 1994.Google Scholar
  19. 19.
    Franca MC Jr, D’Abreu A, Friedman JH, Nucci A, Lopes-Cendes I. Chronic pain in Machado-Joseph disease: a frequent and disabling symptom. Arch Neurol. 2007;64:1767–70.CrossRefPubMedGoogle Scholar
  20. 20.
    Yeh TH, Lu CS, Chou YH, Chong CC, Wu T, Han NH, et al. Autonomic dysfunction in Machado-Joseph disease. Arch Neurol. 2005;62:630–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Schols L, Amoiridis G, Epplen JT, Langkafel M, Przuntek H, Riess O. Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J Neurol Neurosurg Psychiatry. 1996;61:466–70.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    D’Abreu A, França M Jr, Conz L, Friedman JH, Nucci AM, Cendes F, et al. Sleep symptoms and their clinical correlates in Machado-Joseph disease. Acta Neurol Scand. 2009;119:277–80.CrossRefPubMedGoogle Scholar
  23. 23.
    Friedman JH, Fernandez HH, Sudarsky LR. REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3). Mov Disord. 2003;18:1520–2.CrossRefPubMedGoogle Scholar
  24. 24.
    Friedman JH, Amick MM. Fatigue and daytime somnolence in Machado-Joseph disease (spinocerebellar ataxia type 3). Mov Disord. 2008;23:1323–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Pedroso JL, Braga-Neto P, Felício AC, Dutra LA, Santos WA, do Prado GF, et al. Sleep disorders in Machado-Joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-ralated motor and non-motor features. Cerebellum. 2011;10:291–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Braga-Neto P, Pedroso JL, Alessi H, Dutra LA, Felício AC, Minett T, et al. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features. Cerebellum. 2012;11:549–56.CrossRefPubMedGoogle Scholar
  27. 27.
    Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121:561–79.CrossRefPubMedGoogle Scholar
  28. 28.
    Roeske S, Filla I, Heim S, Amunts K, Helmstaedter C, Wüllner U, et al. Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Mov Disord. 2013;28:1435–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Cecchin CR, Pires AP, Rieder CR, Monte TL, Silveira I, Carvalho T, et al. Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives. Community Genet. 2007;10:19–26.CrossRefPubMedGoogle Scholar
  30. 30.
    Schmitz-Hübsch T, Coudert M, Giunti P, Globas C, Baliko L, Fancellu R, et al. Self-rated health status in spinocerebellar ataxia—results from a European multicenter study. Mov Disord. 2010;5:587–95.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de ClínicasFederal University of ParanáCuritibaBrazil
  2. 2.Department of Medicine, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western HospitalUniversity of TorontoTorontoCanada
  3. 3.Advanced Molecular Research Center, Center for Biological and Health SciencesPUCCuritibaBrazil
  4. 4.Postgraduate Program in MedicineUniversidade Nove de JulhoSão PauloBrazil
  5. 5.Methodist Hospital Research InstituteHoustonUSA

Personalised recommendations